During the past decade, Digestive Health Associates of Texas, PA conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Digestive Health Associates of Texas, PA" are "Heartburn" (1 trials), "Non-Erosive Gastro-Esophageal Reflux Disease" (1 trials), "Recurrent C. Difficile Infection" (1 trials) and "Ulcerative Colitis" (1 trials). Many other conditions were trialed in "Digestive Health Associates of Texas, PA" in a lesser frequency.

Most popular intervention types in "Digestive Health Associates of Texas, PA" are "Drug" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "CP101" (1 trials), "Cobitolimod 250 mg" (1 trials), "Cobitolimod 500 mg" (1 trials) and "Vonoprazan" (1 trials). Other intervention names were less common.

The vast majority of trials in "Digestive Health Associates of Texas, PA" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Digestive Health Associates of Texas, PA". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Digestive Health Associates of Texas, PA, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Digestive Health Associates of Texas, PA, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".